Black Rock Inc. Applied Therapeutics Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,569,787 shares of APLT stock, worth $6.57 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,569,787
Previous 989,277
564.1%
Holding current value
$6.57 Million
Previous $6.73 Million
356.07%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding APLT
# of Institutions
80Shares Held
89.6MCall Options Held
152KPut Options Held
186K-
T. Rowe Price Investment Management, Inc. Baltimore, MD18.7MShares$18.7 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY11.5MShares$11.5 Million0.19% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$11.3 Million4.26% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$7.8 Million1.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$4.73 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $48M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...